E31D (p.Glu31Asp) variant of EIF2AK4 (eIF-2-alpha kinase GCN2)
E31D (p.Glu31Asp) in EIF2AK4 (eIF-2-alpha kinase GCN2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.
E31D (p.Glu31Asp) variant details
- p.Glu31Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.209
- REVEL 0.11
- MetaLR 0.09
- MetaSVM -0.88
- CADD 22.70
- PolyPhen-2 0.39
- SIFT 0.11
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available